Periodic Reporting for period 1 - OVAL (The OVAL study for VB-111 treatment of platinum-resistant ovarian cancer)
Project: OVAL
Updated at: 30-04-2024
Project: OVAL
Updated at: 30-04-2024
Project: OVAL
Updated at: 31-12-2023
Project: OVAL
Updated at: 31-12-2023
Project: OVAL
Updated at: 31-12-2023
Project: OVAL
Updated at: 31-12-2023
Project: OVAL
Updated at: 31-07-2023